We are developing a new class of antibiotics to treat udder infections in dairy cows caused by Staphylococcus aureus, a particularly difficult and costly problem for farmers. While udder infections in general cost the Canadian dairy industry over $800?million each year, those caused by S. aureus are especially challenging to treat, often leading to milk […]

MaaTRx is a real-time decision support platform for drug shortages: it allows users to proactively assess risks, collaborate across the supply chain, and plan strategic responses. With a 15% rise in Canadian drug shortages and over 3,000 reported shortages, MaaTRx is built to close this gap. Backed by decades of research, national grants and technical […]

Le projet vise le développement du flacon digital, c’est-à-dire une approche de simulation numérique qui permet d’étudier des réactions chimiques et de prédire les produits qui seront observés en laboratoire. Le flacon digital fournit une vision moléculaire des différentes réactions chimiques possibles, ce qui est autrement impossible à obtenir directement. Une première application de celui-ci […]

Le projet vise à optimiser la production d’un nouvel antibiotique conçu pour traiter les infections du pis chez les vaches, causées par Staphylococcus aureus. Ces infections coûtent très cher à l’industrie laitière et les traitements actuels sont souvent inefficaces ou contrôlés en médecine vétérinaire. Le stagiaire travaillera avec le centre de recherche appliquée Kemitek pour […]

Secreted protein acidic and rich in cysteine (SPARC) is a protein that is more produced by athletes (muscles) compared to sedentary individuals. We have previously shown that this protein is responsible for some exercise-induced effects, its injections also produce exercise-like effects, and its decrease/absence speeds up ageing. Therefore, SPARC could be an exercise substitute – […]

La stagiaire participera à la conception d’encres pharmaceutiques pour l’impression 3D de comprimés mâchables destinés à l’usage pédiatrique. Cette nouvelle technologie permet de fabriquer de façon rapide et sécuritaire des imprimés gélifiés contenant une dose personnalisée d’un ou plusieurs médicaments. La stagiaire mettra au point de nouvelles formulations d’encres imprimables et en assurera la caractérisation, […]

We are developing a promising new technology based on extracellular vesicles (EVs, often referred to as exosomes), which are natural delivery vehicles produced by cells. These tiny particles have the potential to transform how we treat diseases by delivering therapeutic ingredients directly to where they’re needed in the body. To bring this technology to market […]

This project focuses on developing innovative, biocompatible microrobots for targeted drug delivery, particularly in cancer treatment. By integrating smart hydrogels with magneto-active properties, these tiny robots can navigate the body and deliver highly precise chemotherapy drugs, reducing side effects and improving patient outcomes. Advanced 3D microfabrication techniques, such as two-photon lithography and digital light processing, […]

We are developing a new treatment for ischemic stroke using a modified version of a natural anticoagulant called ADAMTS13. Existing stroke therapies are limited by a short treatment window and can carry serious risks. This new approach aims to safely extend the time patients can receive treatment, increasing access, especially for those in rural or […]

NanopHast is developing cutting-edge solid-state pH sensors designed to replace traditional glass pH electrodes. Our sensors offers miniaturized pH measurement, opening up novel possibilities in drug discovery and development. NanopHast has longer shelf life, lower manufacturing costs and a maintenance free design for users. Our goal is to redefine pH measurement standards and help drive […]

This project is focused on developing a novel, plant-based appetite suppressant called ZAP-010. Originally synthesized for agricultural use, ZAP-010 is a phytohormone that we have shown to reduce food intake and promote sustained weight loss in rodent models. Over 60% of Canadian adults are classified as overweight or obese and current treatment options, such as […]

In collaboration with the Lab2Market Validate program, our goal is to transition our natural polymer-based wound dressing from the lab bench to commercial scale. Designed specifically for individuals with chronic wounds and fragile skin conditions, our hydrogel-based dressing aims to fill a critical gap in the market. Through the program, we seek to deepen our […]